L. Bara

5.2k total citations · 1 hit paper
73 papers, 4.1k citations indexed

About

L. Bara is a scholar working on Surgery, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, L. Bara has authored 73 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 26 papers in Hematology and 23 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in L. Bara's work include Blood Coagulation and Thrombosis Mechanisms (24 papers), Heparin-Induced Thrombocytopenia and Thrombosis (18 papers) and Venous Thromboembolism Diagnosis and Management (18 papers). L. Bara is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (24 papers), Heparin-Induced Thrombocytopenia and Thrombosis (18 papers) and Venous Thromboembolism Diagnosis and Management (18 papers). L. Bara collaborates with scholars based in France, United Kingdom and United States. L. Bara's co-authors include M Samama, François Cambien, Dominique Arveiler, Odette Poirier, Jean‐Pierre Cambou, Laurence Tiret, Gérald Luc, Alun Evans, Sylvain Ricard and Laure Lecerf and has published in prestigious journals such as Nature, Circulation and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

L. Bara

70 papers receiving 3.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

1992 1.6k citations François Cambien, Odette Poirier et al. Nature profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
L. Bara	2.3k	1.3k	1.1k	970	955	73	4.1k
B Boneu	2.3k 1.0×	336 0.3×	2.0k 1.9×	2.0k 2.1×	1.5k 1.6×	217	5.8k
Nauder Faraday	1.5k 0.7×	394 0.3×	380 0.4×	706 0.7×	653 0.7×	79	2.8k
Pascale Gaussem	1.6k 0.7×	295 0.2×	920 0.9×	1.2k 1.2×	771 0.8×	186	4.5k
Mark I. Furman	2.3k 1.0×	226 0.2×	834 0.8×	1.6k 1.7×	912 1.0×	50	4.3k
F. Haverkate	1.1k 0.5×	541 0.4×	558 0.5×	1.8k 1.9×	770 0.8×	94	4.7k
Justo Aznar	745 0.3×	311 0.2×	595 0.6×	1.1k 1.1×	405 0.4×	121	2.9k
Wolfgang Speiser	1.1k 0.5×	212 0.2×	1.1k 1.0×	1.5k 1.6×	548 0.6×	90	3.6k
MA Packham	1.2k 0.5×	283 0.2×	298 0.3×	1.7k 1.8×	576 0.6×	96	3.6k
Jørgen Gram	589 0.3×	643 0.5×	336 0.3×	761 0.8×	401 0.4×	167	2.8k
Brigitte Jude	1.4k 0.6×	292 0.2×	433 0.4×	1.2k 1.2×	1.7k 1.8×	133	5.7k

Countries citing papers authored by L. Bara

Since Specialization

Citations

This map shows the geographic impact of L. Bara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Bara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Bara more than expected).

Fields of papers citing papers by L. Bara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Bara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Bara. The network helps show where L. Bara may publish in the future.

Co-authorship network of co-authors of L. Bara

This figure shows the co-authorship network connecting the top 25 collaborators of L. Bara. A scholar is included among the top collaborators of L. Bara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Bara. L. Bara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bara, L., et al.. (2008). Effect of UDP-glucuronyltransferase induction on zearalenone metabolism.. 7. 19–24. 1 indexed citations

Bara, L., et al.. (2005). Determination of prothombinase activation after adding human purified prothrombin to human clot: comparison of hirudin, an activated factor II inhibitor, with DX9065a, an activated factor X inhibitor, on clot-associated thrombin and on prothrombin activation. Blood Coagulation & Fibrinolysis. 16(2). 125–133. 6 indexed citations

Desjardins, Louis, L. Bara, Florent Boutitie, et al.. (2004). Correlation of Plasma Coagulation Parameters With Thromboprophylaxis, Patient Characteristics, and Outcome in the MEDENOX Study. Archives of Pathology & Laboratory Medicine. 128(5). 519–526. 38 indexed citations

Bara, L., André Planès, & Meyer‐Michel Samama. (1999). Occurrence of thrombosis and haemorrhage, relationship with anti‐Xa, anti‐IIa activities, and D‐dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery. British Journal of Haematology. 104(2). 230–240. 84 indexed citations

Gerotziafas, Grigoris, et al.. (1998). Comparative effects of synthetic pentasaccharide, low-molecular-weight heparin, unfractionated heparin and recombinant hirudin on the generation of factor VIIa and prothrombin activation after coagulation of human plasma. Blood Coagulation & Fibrinolysis. 9(7). 571–580. 18 indexed citations

Samama, M, L. Bara, & Isabelle Gouin‐Thibault. (1996). New Data on the Pharmacology of Heparin and Low Molecular Weight Heparins. Drugs. 52(Supplement 7). 8–15. 28 indexed citations

Lane, Anne Marie, Pierre‐Yves Scarabin, Viviane Nicaud, et al.. (1996). Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study. Atherosclerosis. 119(1). 119–127. 80 indexed citations

Tardy, Bernard, B. Tardy-Poncet, L. Bara, et al.. (1996). EFFECTS OF LONG TRAVELS IN SITTING POSITION IN ELDERLY VOLUNTEERS ON BIOLOGICAL MARKERS OF COAGULATION ACTIVATION AND FIBRINOLYSIS. Thrombosis Research. 83(2). 153–160. 20 indexed citations

Gerotziafas, Grigoris, et al.. (1996). Treatment with LMWHs inhibits factor VIIa generation during in vitro coagulation of whole blood. Thrombosis Research. 81(4). 491–496. 12 indexed citations

10.

Bara, L., et al.. (1994). Plasma TFPI activity after intravenous injection of pentasaccharide (PS) and unfractionated heparin in rabbits. Thrombosis Research. 75(5). 577–580. 13 indexed citations

11.

Plu‐Bureau, Geneviève, et al.. (1993). Factor VII activation and oral contraceptives. Thrombosis Research. 70(3). 275–280. 12 indexed citations

12.

Bara, L., et al.. (1992). Correlation between anti-Xa and occurrence of thrombosis and haemorrhage in post-surgical patients treated with either logiparin® (LMWH) or unfractionated heparin. Thrombosis Research. 65(4-5). 641–650. 51 indexed citations

13.

Cambien, François, Odette Poirier, Laure Lecerf, et al.. (1992). Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 359(6396). 641–644. 1552 indexed citations breakdown →

14.

Colas-Linhart, N., et al.. (1991). Pharmacokinetics and biodistribution of technetium 99m labelled standard heparin and a low molecular weight heparin (enoxaparin) after intravenous injection in normal volunteers. British Journal of Haematology. 77(2). 201–208. 30 indexed citations

15.

Bara, L., et al.. (1990). In vitro effect on heptest® of low molecular weight heparin fractions and preparations with various anti-IIa and anti-Xa activities. Thrombosis Research. 57(4). 585–592. 25 indexed citations

16.

Bara, L., et al.. (1990). The inhibition of intrinsic prothrombinase and its generation by heparin and four derivatives in prothrombin poor plasma. Thrombosis Research. 58(5). 445–454. 16 indexed citations

17.

Frydman, Armand, et al.. (1988). The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mg. The Journal of Clinical Pharmacology. 28(7). 609–618. 148 indexed citations

18.

Walenga, Jeanine M., L. Bara, Maurice Petitou, et al.. (1988). The inhibition of the generation of thrombin and the antithrombotic effect of a pentasaccharide with sole anti-factor Xa activity. Thrombosis Research. 51(1). 23–33. 57 indexed citations

19.

Bara, L., et al.. (1986). Partial Reversal of Low Molecular Weight Heparin (PK 10169) Anti-Xa Activity by Protamine Sulfate: In vitro and in vivo Study during Cardiac Surgery with Extracorporeal Circulation. Pathophysiology of Haemostasis and Thrombosis. 16(2). 139–146. 83 indexed citations

20.

Dawes, J., et al.. (1986). Relationship between Biological Activity and Concentration of a Low-Molecular-Weight Heparin (PK 10169) and Unfractionated Heparin after Intravenous and Subcutaneous Administration. Pathophysiology of Haemostasis and Thrombosis. 16(2). 116–122. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact